SG Americas Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,515
Closed -$537K 3586
2026
Q1
$537K Buy
+3,515
New +$539K ﹤0.01% 2141
2025
Q2
Sell
-5,050
Closed -$563K 3388
2025
Q1
$563K Sell
5,050
-5,298
-51% -$564K ﹤0.01% 1678
2024
Q4
$1.01M Sell
10,348
-10,948
-51% -$1.17M ﹤0.01% 864
2024
Q3
$2.45M Buy
21,296
+3,372
+19% +$383K 0.01% 603
2024
Q2
$1.91M Buy
17,924
+2,811
+19% +$282K 0.01% 974
2024
Q1
$1.46M Sell
15,113
-27,934
-65% -$2.86M 0.01% 992
2023
Q4
$4.35M Buy
43,047
+8,724
+25% +$842K 0.04% 386
2023
Q3
$3.5M Buy
34,323
+14,797
+76% +$1.5M 0.04% 436
2023
Q2
$1.97M Buy
19,526
+4,230
+28% +$423K 0.01% 747
2023
Q1
$1.41M Buy
+15,296
New +$1.34M 0.02% 890
2022
Q4
Sell
-1,933
Closed -$147K 3283
2022
Q3
$147K Sell
1,933
-2,841
-60% -$236K ﹤0.01% 2566
2022
Q2
$404K Buy
+4,774
New +$419K ﹤0.01% 2145
2022
Q1
Sell
-11,977
Closed -$1.05M 3300
2021
Q4
$1.05M Sell
11,977
-3,302
-22% -$274K 0.01% 1617
2021
Q3
$1.25M Sell
15,279
-174
-1% -$15.7K 0.01% 1704
2021
Q2
$1.41M Buy
15,453
+631
+4% +$56.2K 0.01% 1335
2021
Q1
$1.27M Sell
14,822
-26,151
-64% -$2.35M 0.01% 1358
2020
Q4
$3.87M Buy
40,973
+20,365
+99% +$1.78M 0.02% 650
2020
Q3
$1.79M Sell
20,608
-11,893
-37% -$1.03M 0.01% 808
2020
Q2
$2.84M Sell
32,501
-28,697
-47% -$2.48M 0.02% 619
2020
Q1
$5.05M Buy
61,198
+12,874
+27% +$1.15M 0.05% 379
2019
Q4
$4.58M Buy
48,324
+22,599
+88% +$2.03M 0.04% 415
2019
Q3
$2.24M Sell
25,725
-63,940
-71% -$5.74M 0.02% 886
2019
Q2
$8.19M Buy
89,665
+64,170
+252% +$5.43M 0.06% 333
2019
Q1
$2.2M Buy
25,495
+3,924
+18% +$315K 0.02% 795
2018
Q4
$1.66M Buy
21,571
+13,012
+152% +$1.01M 0.01% 1000
2018
Q3
$661K Sell
8,559
-29,706
-78% -$2.2M ﹤0.01% 1969
2018
Q2
$2.59M Buy
38,265
+29,706
+347% +$2.05M 0.02% 776
2018
Q1
$620K Sell
8,559
-50,705
-86% -$3.86M 0.01% 1735
2017
Q4
$4.46M Buy
59,264
+3,837
+7% +$290K 0.04% 431
2017
Q3
$4.26M Buy
55,427
+31,427
+131% +$2.37M 0.04% 402
2017
Q2
$1.79M Buy
24,000
+7,816
+48% +$554K 0.02% 967
2017
Q1
$1.08M Sell
16,184
-39,677
-71% -$2.64M 0.01% 1321
2016
Q4
$3.65M Sell
55,861
-73,974
-57% -$4.8M 0.03% 603
2016
Q3
$9.19M Buy
129,835
+65,099
+101% +$4.74M 0.1% 194
2016
Q2
$4.79M Sell
64,736
-39,411
-38% -$2.72M 0.03% 411
2016
Q1
$6.76M Buy
104,147
+4,743
+5% +$323K 0.05% 300
2015
Q4
$7.66M Buy
99,404
+31,530
+46% +$2.5M 0.05% 280
2015
Q3
$5.59M Buy
67,874
+49,527
+270% +$4.41M 0.03% 342
2015
Q2
$1.62M Sell
18,347
-4,638
-20% -$425K 0.01% 817
2015
Q1
$2.03M Buy
22,985
+1,317
+6% +$117K 0.01% 794
2014
Q4
$1.8M Buy
21,668
+610
+3% +$50.6K 0.01% 997
2014
Q3
$1.78M Buy
21,058
+12,276
+140% +$993K 0.01% 927
2014
Q2
$712K Buy
8,782
+223
+3% +$17.5K ﹤0.01% 1521
2014
Q1
$652K Hold
8,559
﹤0.01% 1333
2013
Q4
$616K Hold
8,559
﹤0.01% 1443
2013
Q3
$588K Hold
8,559
﹤0.01% 1530
2013
Q2
$542K Buy
+8,559
New +$557K ﹤0.01% 1219

Other funds holding NVS

SG Americas Securities's NVS Position: Q2 2026 in Review

SG Americas Securities sold out of Novartis (NVS) in Q2 2026, closing a stake of 3,515 shares — an estimated $537K sold.

SG Americas Securities first reported a position in NVS in Q2 2013 and held it in 47 quarters. The position peaked at $9.19M in Q3 2016. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • SG Americas Securities reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 3,515 Novartis shares in Q2 2026, an estimated $537K.
  • SG Americas Securities first reported a position in Novartis in Q2 2013 and held it in 47 quarters.
  • SG Americas Securities's Novartis position peaked at $9.19M in Q3 2016.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.